Oncology Imaging
This article was originally published in The Gray Sheet
Executive Summary
Interagency Council on Biomedical Imaging in Oncology, including representatives from FDA, the Health Care Financing Administration, and the National Institutes of Health's National Cancer Institute, will hold its next meeting Nov. 20, NIH says. The multi-agency group, which had its inaugural meeting in July as a sounding board for advice to investigators and manufacturers seeking to market new imaging technology, is accepting requests to be heard until Oct. 9. The council had reviewed 18 requests from large and small firms, as well as from members of academia. The meeting is closed to the public